[{"address1": "3300 Nacogdoches Road", "address2": "Suite 216", "city": "San Antonio", "state": "TX", "zip": "78217", "country": "United States", "phone": "210 698 5334", "website": "https://www.bioaffinitytech.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Steven  Girgenti", "age": 78, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 115430, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Zannes J.D.", "age": 68, "title": "Founder, President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 327157, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Xavier T. Reveles M.S.", "age": 54, "title": "Chief Operating Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William  Bauta Ph.D.", "title": "Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy P. Zannes J.D.", "age": 71, "title": "Executive VP, Secretary & General Counsel", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie Anne Overton", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dallas J. Coleman", "title": "Vice President of sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gordon  Downie M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.88, "open": 1.8, "dayLow": 1.76, "dayHigh": 1.9954, "regularMarketPreviousClose": 1.88, "regularMarketOpen": 1.8, "regularMarketDayLow": 1.76, "regularMarketDayHigh": 1.9954, "payoutRatio": 0.0, "beta": 2.329, "forwardPE": -3.0666666, "volume": 120737, "regularMarketVolume": 120737, "averageVolume": 2875194, "averageVolume10days": 138760, "averageDailyVolume10Day": 138760, "bid": 1.79, "ask": 1.89, "bidSize": 1, "askSize": 1, "marketCap": 6758114, "fiftyTwoWeekLow": 1.76, "fiftyTwoWeekHigh": 46.53, "allTimeHigh": 466.5, "allTimeLow": 1.88, "priceToSalesTrailing12Months": 0.87984145, "fiftyDayAverage": 3.7998, "twoHundredDayAverage": 9.8727, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1595882, "profitMargins": -1.52179, "floatShares": 890845, "sharesOutstanding": 3633815, "sharesShort": 109788, "sharesShortPriorMonth": 807535, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.024400001, "heldPercentInsiders": 0.046479996, "heldPercentInstitutions": 0.03742, "shortRatio": 0.04, "shortPercentOfFloat": 0.025, "impliedSharesOutstanding": 3672888, "bookValue": -2.274, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11688941, "trailingEps": -17.1, "forwardEps": -0.6, "lastSplitFactor": "1:30", "lastSplitDate": 1758240000, "enterpriseToRevenue": 0.208, "enterpriseToEbitda": -0.168, "52WeekChange": -0.95323384, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 1.84, "recommendationKey": "none", "totalCash": 802835, "totalCashPerShare": 0.855, "ebitda": -9490369, "totalDebt": 669997, "quickRatio": 0.473, "currentRatio": 0.645, "totalRevenue": 7681059, "revenuePerShare": 13.658, "returnOnAssets": -1.10268, "returnOnEquity": -18.0245, "grossProfits": 2294273, "freeCashflow": -3465642, "operatingCashflow": -7675376, "revenueGrowth": -0.471, "grossMargins": 0.29869, "ebitdaMargins": -1.23555, "operatingMargins": -1.9815601, "financialCurrency": "USD", "symbol": "BIAF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1662039000000, "postMarketChangePercent": 1.6304332, "postMarketPrice": 1.87, "postMarketChange": 0.029999971, "regularMarketChange": -0.04, "regularMarketDayRange": "1.76 - 1.9954", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2875194, "fiftyTwoWeekLowChange": 0.08000004, "fiftyTwoWeekLowChangePercent": 0.04545457, "fiftyTwoWeekRange": "1.76 - 46.53", "fiftyTwoWeekHighChange": -44.69, "fiftyTwoWeekHighChangePercent": -0.9604556, "fiftyTwoWeekChangePercent": -95.32339, "earningsTimestampStart": 1755174600, "earningsTimestampEnd": 1755174600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -17.1, "epsForward": -0.6, "epsCurrentYear": -14.40001, "priceEpsCurrentYear": -0.1277777, "fiftyDayAverageChange": -1.9597999, "fiftyDayAverageChangePercent": -0.515764, "twoHundredDayAverageChange": -8.0327, "longName": "bioAffinity Technologies, Inc.", "twoHundredDayAverageChangePercent": -0.8136275, "priceToBook": -0.80914694, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-08-25", "cryptoTradeable": false, "regularMarketChangePercent": -2.12766, "regularMarketPrice": 1.84, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1763164091, "regularMarketTime": 1763154002, "exchange": "NCM", "messageBoardId": "finmb_423045573", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "bioAffinity Technologies, Inc.", "displayName": "bioAffinity", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]